Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19
Food and Drug Administration has identified certain bulk drug substances used in compounding as substances that may present significant safety risks, and BPC-157 has been discussed in that regulatory context
Its your first choice
Another rat study examining spinal cord injury found that BPC-157-treated animals showed consistent clinical improvement, including better motor function and earlier resolution of spasticity
Transparent quality control processes can help laboratories maintain confidence in research materials and improve consistency across experiments
Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System, Sikiric P, Seiwerth S, Skrtic A, Staresinic M, Strbe S, Vuksic A, Sikiric S, Bekic D, Soldo D, Grizelj B, Novosel L, Beketic Oreskovic L, Oreskovic I, Stupnisek M, Boban Blagaic A, Dobric I, Pharmaceuticals (Basel), Pharmaceuticals, 2025 Jun 19;18(6):928
20 interactions Metformin Metformin Hydrochloride Metformin, Sitagliptin Alogliptin, Metformin Canagliflozin, Metformin Canagliflozin, Metformin Hydrochloride Dapagliflozin Propanediol, Metformin Dapagliflozin, Metformin Hydrochloride, Saxagliptin Hydrochloride Empagliflozin, Linagliptin, Metformin Hydrochloride Empagliflozin, Metformin Empagliflozin, Metformin Hydrochloride Ertugliflozin, Metformin Hydrochloride Glipizide, Metformin Glyburide, Metformin Linagliptin, Metformin Hydrochloride Metformin, Linagliptin Metformin, Rosiglitazone Pioglitazone, Metformin Saxagliptin, Metformin Xr Sitagliptin, Metformin No interaction 2,809 drugs checked show the list We also checked Vitamin B12 against these medications and found no known interaction in our sources
US$ 26.92
US$ 21.69
US$ 23.32
US$ 27.90
US$ 26.60
